Administration of selegiline is not associated with visual hallucinations in advanced Parkinson's disease patients.
Papapetropoulos
S
S
Argyriou
A A
AA
D000978:Antiparkinson Agents / Q000008:administration & dosage* / Q000009:adverse effects; D006212:Hallucinations / Q000139:chemically induced*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D012642:Selegiline / Q000008:administration & dosage* / Q000009:adverse effects
D000978:Antiparkinson Agents; D012642:Selegiline